Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages.

Bacterial DNA containing unmethylated CpG dinucleotides (CpG DNA) is a potent immune stimulating agent that holds strong promise in the treatment of many disorders. Studies have established that CpG DNA triggers an immune response through activated expression of genes in immune cells including macrophages. To dissect further the molecular mechanism(s) by which CpG DNA activates the immune system, we studied macrophage gene expression profiles in response to CpG DNA using microarray technology. Since CpG DNA is reported to use the TLR9 receptor that shares homology with the TLR4 receptor used by bacterial lipopolysaccharide (LPS), we also evaluated gene expression profiles in macrophages stimulated by LPS versus CpG DNA. Both CpG DNA and LPS modulate expression of a large array of genes. However, LPS modulated the expression of a much greater number of genes than did CpG DNA and all genes induced or repressed by CpG DNA were also induced or repressed by LPS. These data indicate that the CpG DNA signaling pathway through TLR9 activates only a subset of genes induced by the LPS TLR4 signaling pathway.

[1]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[2]  M. Byrne,et al.  Preparation of mRNA for Expression Monitoring , 2001, Current protocols in neuroscience.

[3]  K. Heeg,et al.  Bacterial DNA as immune cell activator. , 1998, Trends in microbiology.

[4]  D. Morrison,et al.  Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. , 1999, Journal of immunology.

[5]  G. Weiner.  The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides , 2000, Journal of leukocyte biology.

[6]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[7]  B. Beutler,et al.  Three novel mammalian toll-like receptors: gene structure, expression, and evolution. , 2000, European cytokine network.

[8]  D. Hume,et al.  Macrophage activation by immunostimulatory DNA. , 2000, Current topics in microbiology and immunology.

[9]  S. Akira,et al.  Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88 , 2000, Current Biology.

[10]  C. Papasian,et al.  Bacterial DNA and Lipopolysaccharide Induce Synergistic Production of TNF-α Through a Post-Transcriptional Mechanism1 , 2001, The Journal of Immunology.

[11]  H. Häcker,et al.  Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  K. Heeg,et al.  CpG DNA as a Th1 Trigger , 2000, International Archives of Allergy and Immunology.

[13]  J. Kline.  Effects of CpG DNA on Th1/Th2 balance in asthma. , 2000, Current topics in microbiology and immunology.

[14]  S. Akira,et al.  Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.

[15]  D. Pisetsky.  Immune activation by bacterial DNA: a new genetic code. , 1996, Immunity.

[16]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[17]  P. Klimiuk,et al.  Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes , 2004, Springer Seminars in Immunopathology.

[18]  K. Heeg,et al.  Bacterial DNA causes septic shock , 1997, Nature.